Now in its third year, the Lab of the future survey is a collaboration between Pistoia Alliance and Lab of the Future Congress (Open Pharma Research) bringing together unique insights into how the life sciences R&D environment is evolving. Within this webinar we will provide valuable insights to the community, highlight key industry touch points, […]
Dr. O. Barberan’s presentation highlights a paradigm shift in toxicology, driven by AI, ML, and NAMs, to fundamentally replace traditional animal testing. By integrating human-relevant models—such as organoids, high-content imaging, and mechanistic computational tools—the approach aims to overcome the predictive shortcomings of animal models, particularly species differences and translational failures in DILI. Evidence shows […]
In pharma R&D, UX design is the difference between an AI breakthrough that changes how scientists work and a promising model that never leaves the lab. Exploring how the future of AI in pharma R&D depends not just on the technology itself, but on the experience of the people using it, this webinar brings […]
In vivo efficacy studies generate critical data for drug discovery, but the absence of agreed standards leads to fragmented, inconsistent, and difficult-to-reuse data sets. Current approaches rely on bespoke formats across pharma, CROs, and technology providers, making integration, regulatory submission, and AI-driven analysis inefficient and error-prone. While CDISC SEND provides a proven framework for toxicology […]
Join us for a thought-provoking virtual roundtable bringing together experts from across industry and academia to discuss the evolving role of omics standards in drug discovery, translational research, and clinical trials. Speakers include: Bron Kisler – The Genomics and Omics Standards Landscape Adrian Czaban (Novo Nordisk) – CDISC Clinical Trial Use Case Dr. Jonathon Keeney (BioCompute / […]
